Amdocs (DOX)
(Delayed Data from NSDQ)
$85.64 USD
-1.10 (-1.27%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $85.65 +0.01 (0.01%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth F Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
DOX 85.64 -1.10(-1.27%)
Will DOX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for DOX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DOX
DOX or DT: Which Is the Better Value Stock Right Now?
DOX vs. DT: Which Stock Is the Better Value Option?
DOX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Amdocs (DOX) to Support Software for DELTA's Monetization Engine
CoStar (CSGP) Up 14.7% Since Last Earnings Report: Can It Continue?
Want Better Returns? Don't Ignore These 2 Computer and Technology Stocks Set to Beat Earnings
Other News for DOX
Dividend Champion, Contender, And Challenger Highlights: Week Of April 21
Amdocs: Financial Prospects And Capital Return Are Key Investment Considerations
Amdocs Enters Oversold Territory
House eyes extension of pandemic-era Medicare telehealth benefits, Axios reports
3 Under-the-Radar Technology Stocks to Buy for Multibagger Returns